In conclusion, this work establishes a new role for EVs in driving breast cancer metastasis via hyperactivation of the TGF-β signaling in cancer cells, a previously poorly characterized phenomenon that may explain the failure in translating TGF-β signaling inhibitors from bench-to-bedside. This evidence concerns the gene TGFB1 and breast cancer.